Prednisolone and deflazacort are both systemic glucocorticoids used to treat inflammation and immune-related conditions. The main differences are in how they’re activated in the body, their side‑effect profiles, and how they’re dosed.
Key points
- What they are
- Prednisolone: active glucocorticoid. Often used in many inflammatory conditions (asthma, inflammatory arthritis, flares of autoimmune diseases).
- Deflazacort: a prodrug that’s converted in the body to an active metabolite. Used for similar inflammatory/autoimmune conditions; in some countries it’s also used for Duchenne muscular dystrophy (DMD).
- Potency and dosing
- Both can achieve similar anti-inflammatory effects at appropriate doses, but the mg-for-mg potency isn’t always exactly the same. Dosing depends on the condition, patient factors, and whether you’re treating an acute flare or taking a steroid for long-term control.
- In practice, clinicians use approved equivalence tables to switch between them. For example, in DMD, deflazacort is often used at about 0.9 mg/kg/day, which is considered roughly comparable in effect to prednisone/prednisolone at about 0.75 mg/kg/day. This is a disease-specific guideline and not a general rule for all conditions.
- Important: never switch between these medications or adjust dose without medical advice, because dosing is disease- and patient-specific.
- Side effects and safety profile
- Common to both: increased infection risk, hyperglycemia, weight gain, mood changes, high blood pressure, stomach ulcers, thinning of bones (osteoporosis), cataracts/glaucoma with long-term use, adrenal suppression, and slower growth in children with long-term use.
- Deflazacort-specific observations (from various studies):
- Some data suggest it may cause less weight gain and less growth retardation in children compared with prednisone/prednisolone at similar anti-inflammatory effects.
- Some studies in Duchenne muscular dystrophy have suggested a favorable tolerability profile in certain aspects, but results are not universal.
- Prednisolone-specific notes:
- More data across a broad range of conditions, with well-established dosing guidelines; some patients report more fluid retention or weight gain in some regimens, though this varies.
- Eye effects (cataracts, glaucoma) and mood/psychiatric effects can occur with either medication with long-term use.
- Practical considerations
- Availability and cost vary by country.
- Formulations: both come in oral tablets; prednisolone also has IV forms for hospital use in some settings.
- Pregnancy: prednisone/prednisolone is the most studied in pregnancy and is often preferred because placental enzymes reduce fetal exposure. Deflazacort has less well-established safety data in pregnancy; discuss with a clinician if pregnancy is a consideration.
Always taper when stopping or reducing dose to avoid withdrawal and flare of the underlying disease.
- What this means for you
- If you’re choosing between them, the decision depends on the disease being treated, your response to steroids, risk factors (bone health, blood sugar, growth concerns in kids), and what’s available/affordable in your country.
- Some clinicians prefer deflazacort for certain patients (e.g., children or patients where growth/weight concerns are important) because of a possibly more favorable long-term side-effect profile, but this is not universal.
- For specific dosing, conversion, and monitoring plans, follow your doctor’s instructions and consult them if you’re considering switching steroids.
If you’d like, tell me:
- The condition being treated (e.g., asthma, rheumatoid arthritis, DMD, etc.),
- Your age (adult or child),
- Country or region (for availability and guidelines),
- Any health factors (diabetes, osteoporosis, pregnancy, etc.).
I can tailor a more precise comparison and discuss practical dosing considerations and monitoring for your situation.